Thanks for posting Daniel, great interview!
Rachel, if you're reading, excellent job... it's always a pleasure to watch a well presented journalist ask short, sharp, relevant questions.
Wayne is a fantastic interviewee, comes across so well, so competent and backs up what our Chairman John Seaberg said at the last AGM, that Wayne would be right at home amongst any of the CEO's from Fortune 500 companies. We are lucky to have him!
The last exchange I found the best and also the most illuminating and encouraging for current and prospective investors, keeping in mind an earlier excerpt,
"We've a portfolio of products built around the ADAPT technology process. ADAPT is very unique, it creates an unassailable moat around the company based on the clinical data and published data that we have supporting our claims of clinical superiority."
Rachael Jones: The last question Wayne, what are the priorities for the next six months and longer term?
Wayne Paterson: The key priority for us is to really make sure that we drive forward the portfolio commercially in the US and Europe particularly. That we continue to develop our pipeline, we have a very rich pipeline, 16 projects, predominately as 3D products and then we continued to progress the Tavr project forward during this year and take that to the experimental stage in animal models before the end of this year.
Big, big year coming up!
Expand
